Sun Pharma inks agreement with Israeli & Spanish institutes

Q.  Which pharma major is going to develop the products for treating neurological diseases such as brain stroke and glioblastoma, a lethal brain cancer?
- Published on 11 Dec 15

a. Ranbaxy
b. Sun
c. GlaxoSmithKline
d. None of the above

ANSWER: Sun
 
- Scientists at Israel based Weizmann Institute of Science and Spain’s health research institute have joined hands with Sun Pharma to develop products for treating neurological diseases such as brain stroke.
- Scientists at Weizmann have developed a recombinant enzyme currently undergoing animal studies for indications of brain stroke and glioblastoma. Further studies of this enzyme will be conducted at the Health Research Institute in Spain.

Related Content

➨ Post your comment / Share knowledge


Enter the code shown above:

(Note: If you cannot read the numbers in the above image, reload the page to generate a new one.)
▲